India to United States: Pazopanib Export Trade Route
India has recorded 46 verified shipments of Pazopanib exported to United States, representing a combined trade value of $6.9M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $148.9K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 78% of total export value with 7 shipments worth $5.4M USD. On the buying side, SUN PHARMACEUTICAL INDUSTRIES INC is the largest importer in United States with $3.3M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, TEYRO LABS PRIVATE LIMITED — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Pazopanib corridor is one of India's established pharmaceutical export routes, with 46 shipments documented worth a combined $6.9M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 78% of all export value, reflecting the consolidated nature of India's pazopanib manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $148.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with pazopanib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 15.8%, placing it at rank #9 among India's top pazopanib export destinations globally.
On the import side, key buyers of Indian pazopanib in United States include SUN PHARMACEUTICAL INDUSTRIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC., M/S.NOVUGEN ONCOLOGY SDN.BHD and 18 others. SUN PHARMACEUTICAL INDUSTRIES INC is the single largest importer with 3 shipments valued at $3.3M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#9
- Annual growth+15.8%
- Demand growth+15.6%
- Regulatory ease72/100
Top 10 Indian Pazopanib Exporters to United States
Showing top 10 of 10 Indian suppliers exporting Pazopanib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $767.8K per shipment | 7 | $5.4M | 78.5% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LTD Avg $1.0M per shipment | 1 | $1.0M | 14.6% |
| 3 | TEYRO LABS PRIVATE LIMITED Avg $47.1K per shipment | 6 | $282.3K | 4.1% |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED Avg $129.6K per shipment | 1 | $129.6K | 1.9% |
| 5 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $2.9K per shipment | 17 | $49.0K | 0.7% |
| 6 | ATLAS ENTERPRISES Avg $790 per shipment | 8 | $6.3K | 0.1% |
| 7 | VINAYAK ASSOCIATES Avg $1.1K per shipment | 2 | $2.2K | 0.0% |
| 8 | KOIT BIOPHARMA PRIVATE LIMITED Avg $1.9K per shipment | 1 | $1.9K | 0.0% |
| 9 | 3S CORPORATION Avg $627 per shipment | 2 | $1.3K | 0.0% |
| 10 | 3S PHARMACEUTICALS INDIA PRIVATE LIMITED Avg $240 per shipment | 1 | $240 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting pazopanib to United States, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, TEYRO LABS PRIVATE LIMITED, EUGIA PHARMA SPECIALITIES LIMITED, MYGENIC HEALTHCARE PRIVATE LIMITED, ATLAS ENTERPRISES, VINAYAK ASSOCIATES, KOIT BIOPHARMA PRIVATE LIMITED, 3S CORPORATION, 3S PHARMACEUTICALS INDIA PRIVATE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 7 shipments worth $5.4M USD, giving it a 78% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Top 10 Pazopanib Importers in United States
Showing top 10 of 21 known buyers in United States receiving Pazopanib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian pazopanib in United States include SUN PHARMACEUTICAL INDUSTRIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC., M/S.NOVUGEN ONCOLOGY SDN.BHD, AUROBINDO PHARMA USA., INC,, VERONICA HERNANDEZ HDZ, among 21 total buyers. The largest importer is SUN PHARMACEUTICAL INDUSTRIES INC, accounting for $3.3M USD across 3 shipments — representing 48% of all pazopanib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES INC | 3 | $3.3M | 48.2% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES,INC. | 5 | $3.1M | 44.9% |
| 3 | M/S.NOVUGEN ONCOLOGY SDN.BHD | 6 | $282.3K | 4.1% |
| 4 | AUROBINDO PHARMA USA., INC, | 1 | $129.6K | 1.9% |
| 5 | VERONICA HERNANDEZ HDZ | 4 | $14.9K | 0.2% |
| 6 | LUIS MENDEZ | 2 | $6.0K | 0.1% |
| 7 | SALVADOR DELA TORRE | 1 | $5.7K | 0.1% |
| 8 | SALVADOR DE LA TORRE | 1 | $5.0K | 0.1% |
| 9 | Angel Renteria Salvador | 1 | $4.5K | 0.1% |
| 10 | JULIO MAGALLON GARCIA BRICER | 2 | $4.4K | 0.1% |
Showing top 10 of 21 Pazopanib importers in United States on this route.
Top 10 Pazopanib Formulations Imported by United States
Showing top 10 of 33 product formulations shipped on the India to United States Pazopanib route, ranked by trade value
United States imports a wide range of pazopanib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PAZOPANIB TABLETS 200 MG [PACK: 120 CRC] — accounts for $2.3M USD across 2 shipments. There are 33 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PAZOPANIB TABLETS 200 MG [PACK: 120 CRC] | 2 | $2.3M | 33.5% |
| 2 | PAZOPANIB TABLETS 200 MG 120 BTL US PACK: 120 CRC (BATCH NO AS PER INVOICE) | 3 | $1.8M | 25.8% |
| 3 | PAZOPANIB TABLETS 200 MG 120 BTL USNOS | 1 | $1.1M | 16.7% |
| 4 | PAZOPANIB TABLETS 200 MG 120 BTL US PACK: 120 CRC Batch No. As Per DOCUMENT | 1 | $1.0M | 14.6% |
| 5 | PAZOPANIB TABLETS 200 MG 120 BTL US PACK: 120 CRC | 1 | $169.3K | 2.5% |
| 6 | PAZOPANIB TABLETS 200 MG (PAZOPANIB TABLETS 200 MG - US (HDPE 120 S)) (QTY: 385PACKS) | 1 | $129.6K | 1.9% |
| 7 | PAZOPANIB 200MG TABLETS 120'S BATCH NO.501A23006 | 1 | $60.6K | 0.9% |
| 8 | PAZOPANIB 200MG TABLETS 120'S BATCH NO.501A23005 | 1 | $59.7K | 0.9% |
| 9 | PAZOPANIB 200MG TABLETS 120'S BATCH NO.501A23004 | 1 | $58.8K | 0.9% |
| 10 | PAZOPANIB 200MG TABLETS 120'S BATCH NO.501A23002 | 1 | $42.2K | 0.6% |
Showing top 10 of 33 Pazopanib formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 18 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's pazopanib exports to United States are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 7 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, TEYRO LABS PRIVATE LIMITED — together account for 97% of total trade value on this route. The average shipment value of $148.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as pazopanib tablets 200 mg 120 btl us pack: 120 crc (batch no as per invoice) and pazopanib tablets 200 mg 120 btl usnos, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMACEUTICAL INDUSTRIES INC is the largest importer with 3 shipments worth $3.3M USD — representing 48% of all pazopanib imports from India on this route. A total of 21 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $6.9M
- Avg. Shipment
- $148.9K
- Suppliers
- 10
- Buyers
- 21
- Transit (Sea)
- ~17 days
- Annual Growth
- +15.8%
Reverse Direction
United States → India — Pazopanib (Import)Other Pazopanib Routes
Unlock the Full India to United States Pazopanib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 46 shipments on this route.
Frequently Asked Questions — India to United States Pazopanib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Pazopanib to United States?
The leading Indian exporters of Pazopanib to United States are SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LTD, TEYRO LABS PRIVATE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 78% of total trade value on this route.
Q What is the total value of Pazopanib exports from India to United States?
India exports Pazopanib to United States worth approximately $6.9M USD across 46 recorded shipments. The average value per shipment is $148.9K USD.
Q Which ports does India use to ship Pazopanib to United States?
The most active port of origin is SAHAR AIR with 18 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to United States for Pazopanib?
The average transit time for Pazopanib shipments from India to United States is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Pazopanib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.8% with demand growth tracking at 15.6%. The route is ranked #9 among India's top Pazopanib export destinations globally.
Q How many suppliers are active on the India to United States Pazopanib route?
There are currently 10 active Indian suppliers exporting Pazopanib to United States. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 78% of total shipment value.
Q Who are the main importers of Pazopanib from India in United States?
The leading importers of Indian Pazopanib in United States include SUN PHARMACEUTICAL INDUSTRIES INC, SUN PHARMACEUTICAL INDUSTRIES,INC., M/S.NOVUGEN ONCOLOGY SDN.BHD, AUROBINDO PHARMA USA., INC,, VERONICA HERNANDEZ HDZ. SUN PHARMACEUTICAL INDUSTRIES INC is the largest buyer with 3 shipments worth $3.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Pazopanib.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 21 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 46 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
46 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists